The assessment of patient-reported outcomes (PROs) in clinical trials poses a number of potential problems. What happens when a patient reports a severe symptom and no one is monitoring that information; for example, when questionnaires are not reviewed until the end of a study? Do hospitals or researchers face liability if a patient reports suicidal thoughts on a questionnaire?
Investigators and institutional review boards (IRBs) are increasingly concerned about the risks to patients, and the potential legal liability, when PRO information is not reviewed to detect concerning levels of psychological distress or physical symptoms that may require an immediate response.1 These so-called PRO alerts may present as extreme scores on questionnaires, in additional information provided by a patient, or in a discussion between a patient and research personnel. However, in all cases, the overarching priority must be to ensure the safety and well-being of patients participating in clinical trials.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.